Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/04/2025 ,inter alia, to consider and approve We wish to inform you that ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Tejnaksh Healthcare has informed BSE that its Board of Directors meeting, originally scheduled for April 12, 2025, has been postponed to April 15, 2025. The key agenda is to consider and approve the Draft Letter of Offer for a proposed Right Issue of Equity Shares. The company has also confirmed that the trading window for insiders remains closed from April 1, 2025, until 48 hours after Q4 FY25 financial results are made public. This is a routine SEBI Regulation 29 compliance filing ahead of the board meeting.
A proposed rights issue means the company plans to raise fresh capital from existing shareholders, which may lead to share dilution if not fully subscribed. Shareholders should watch for the Draft Letter of Offer details, including issue price and ratio, once approved on April 15.